Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

NCT04222413 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

116

Enrollment

NIH

Sponsor class

Conditions

Advanced Solid Tumors
Metastatic Pancreatic Cancer
Pediatric Solid Tumor
Advanced Breast Cancer
Malignant Peripheral Nerve Sheath Tumor
Colorectal Neoplasms

Interventions

DRUG: Metarrestin

Sponsor

National Cancer Institute (NCI)